CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $25,980
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-09-10 | EPIC PHARMA LLC 10% owner | Grant or award · Series E Convertible Preferred Stock | +250 | $1,000.00 | $250K | 2,187.5 |
| 2012-09-10 | EPIC INVESTMENTS, LLC 10% owner | Grant or award · Series E Convertible Preferred Stock | +250 | $1,000.00 | $250K | 2,187.5 |
| 2012-06-29 | NIGALAYE ASHOK G Chief Scientific Officer | Grant or award · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | NARINE JEENARINE Director | Grant or award · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | EPIC PHARMA LLC 10% owner | Grant or award · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | EPIC INVESTMENTS, LLC 10% owner | Grant or award · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | POTTI RAM Director | Grant or award · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | NARINE JEENARINE Director | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | NARINE JEENARINE Director | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | POTTI RAM Director | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | NIGALAYE ASHOK G Chief Scientific Officer | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | EPIC PHARMA LLC 10% owner | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-29 | EPIC INVESTMENTS, LLC 10% owner | Purchase · Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $188K | 1,937.5 |
| 2012-06-19 | Ward Carter Julian Chief Financial Officer | Grant or award · Options | +150,000 | 150,000 | ||
| 2012-05-04 | Ward Carter Julian Chief Financial Officer & Sec. | Other acquisition | +1,355,014 | $0.04 | $50K | 1,870,747 |
| 2012-05-04 | POTTI RAM Director | Other disposition | −9,214,097 | $0.04 | $340K | 27,369,355 |
| 2012-05-04 | NARINE JEENARINE Director | Other disposition | −9,214,097 | $0.04 | $340K | 27,777,304 |
| 2012-05-04 | NIGALAYE ASHOK G Chief Scientific Officer | Other disposition | −9,214,097 | $0.04 | $340K | 27,777,304 |
| 2012-05-04 | EPIC PHARMA LLC 10% owner | Other disposition | −9,214,097 | $0.04 | $340K | 27,137,722 |
| 2012-05-04 | EPIC INVESTMENTS, LLC 10% owner | Other disposition | −9,214,097 | $0.04 | $340K | 27,137,722 |
Page 21 of 28 · 542 trades